Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M8FL
|
||||
Former ID |
DNC012481
|
||||
Drug Name |
2,3,4,5-Tetrahydro-benzo[f][1,4]oxazepine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534195] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H11NO
|
||||
Canonical SMILES |
C1COC2=CC=CC=C2CN1
|
||||
InChI |
1S/C9H11NO/c1-2-4-9-8(3-1)7-10-5-6-11-9/h1-4,10H,5-7H2
|
||||
InChIKey |
HDVHFHONOKCUHQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534195] | |
Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534195] | ||
Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534195] | ||
Reactome | Adrenoceptors | ||||
Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
Adrenaline,noradrenaline inhibits insulin secretion | |||||
G alpha (i) signalling events | |||||
G alpha (z) signalling events | |||||
Surfactant metabolismR-HSA-390696:Adrenoceptors | |||||
G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors | |||||
Surfactant metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.